Schedule 13D ownership disclosure

TETRALOGIC PHARMACEUTICALS COR

Security class unavailable · CUSIP: 88165U109

Event date: 2016-01-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,963,643
Percent of class
16.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-094208
Form type
SC 13D/A
Filer
Clarus Lifesciences II, L.P.
CIK
CIK 1431443
Filed
Feb 05, 2016
Reporting period
Jan 26, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub